GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

Isao Date; Mizuho Aoi; Susumu Tomita; Frank Collins; Takashi Ohmoto

doi:10.1097/00001756-199807130-00039

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

Isao Date, Mizuho Aoi, Susumu Tomita, Frank Collins, Takashi Ohmoto

Research output: Contribution to journal › Article › peer-review

49 Citations (Scopus)

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.

Original language	English
Pages (from-to)	2365-2369
Number of pages	5
Journal	NeuroReport
Volume	9
Issue number	10
DOIs	https://doi.org/10.1097/00001756-199807130-00039
Publication status	Published - Jul 13 1998

Keywords

Ageing
Dopamine
GDNF
Parkinson's disease

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1097/00001756-199807130-00039

Cite this

@article{fc1f05bb271c43a987ff12f61ef54432,

title = "GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice",

abstract = "Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.",

keywords = "Ageing, Dopamine, GDNF, Parkinson's disease",

author = "Isao Date and Mizuho Aoi and Susumu Tomita and Frank Collins and Takashi Ohmoto",

year = "1998",

month = jul,

day = "13",

doi = "10.1097/00001756-199807130-00039",

language = "English",

volume = "9",

pages = "2365--2369",

journal = "NeuroReport",

issn = "0959-4965",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

AU - Date, Isao

AU - Aoi, Mizuho

AU - Tomita, Susumu

AU - Collins, Frank

AU - Ohmoto, Takashi

PY - 1998/7/13

Y1 - 1998/7/13

N2 - Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.

AB - Glial cell line-derived neurotrophic factor (GDNF) is a member of the transforming growth factor β super-family and acts as a neurotrophic factor for the nigrostriatal dopaminergic system. GDNF was injected stereotaxically into the striatum of young (2 months old) and aged (12 months old) C57BL/6 mice that were treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) 1 week earlier. Immunocytochemical and neurochemical analyses showed significant recovery of the nigrostriatal dopaminergic system both in young and in aged mice. Since Parkinson's disease is a neurodegenerative disorder mainly affecting elderly people, this result demonstrates the potential usefulness of GDNF in treating Parkinson's disease.

KW - Ageing

KW - Dopamine

KW - GDNF

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0032514206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032514206&partnerID=8YFLogxK

U2 - 10.1097/00001756-199807130-00039

DO - 10.1097/00001756-199807130-00039

M3 - Article

C2 - 9694229

AN - SCOPUS:0032514206

VL - 9

SP - 2365

EP - 2369

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 10

ER -

GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged Parkinsonian mice

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this